Kaplan–Meier analysis revealed that a low expression of either GSTM3 or 4-HNE was associated with poor overall survival and progression-free survival in NPC patients (Fig. 6f, g). This evidence concerns the gene GSTM3 and nasopharyngeal carcinoma.